We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Investigation of the presence of microplastics and their clinical significance in patients with exacerbation and stable periods of chronic obstructive pulmonary disease
Summary
Researchers examined the presence of microplastics in sputum and bronchoalveolar lavage samples from chronic obstructive pulmonary disease (COPD) patients during exacerbation and stable phases. MPs were detected in a majority of patient samples, and their presence was associated with greater airway inflammation, suggesting inhaled microplastics contribute to COPD pathology.
Introduction: It is known that microplastics (MPs) can cause proinflammatory results when taken through the digestive tract. However, their importance on lung through inhalation is unknown. This study aimed to examine the presence and effects of MCs in patients with chronic obstructive lung disease (COPD). Method: Cases were grouped as COPD-exacerbation (E) (n: 33) and -stable (S) (N: 35) and control (N: 32). Demographic characteristics, laboratory parameters, respiratory function tests, and sputum samples were obtained. MPs were examined in sputum samples under a microscope. Results: MPs were present in all groups, and their mean levels were as follows: 1.53±0.63 units/ml in COPD-E, 0.60±0.47 units/ml in COPD-S, and 0.36±0.24 units/ml in the control group (p=<0.001). Furthermore, MPs were found to be higher in COPD patients with respiratory failure (p=0.01) and in patients exposed to biomass than others (p=0.021). Age and smoking together were positively predicted to MPs in sputum (B=-0.272 for age; p=0.05)(B=-0.005 for pack-years; p=0.07). High MPs levels were associated with increased risk of COPD exacerbation (OR=66.09). Levels of MPs negatively predicted FEV1(L) (B=-0.171; p=0.03), but positively predicted the number of hospitalizations (B=0.342; p=0.02) and emergency admissions due to COPD (B=0.758; p=0.02). Conclusion: This study showed that MPs existed in the sputum of not only in COPD patients, but also in healthy control cases. MPs were significantly higher in patients with COPD-E than with COPD-S and control groups. We suggest that exposure to MPs may be a new risk factor for COPD exacerbations.
Sign in to start a discussion.
More Papers Like This
Potential toxicity of micro- and nanoplastics in primary bronchial epithelial cells of patients with chronic obstructive pulmonary disease
Researchers investigated how micro- and nanoplastics affect lung cells taken from patients with chronic obstructive pulmonary disease (COPD), a condition that already impairs breathing. The study aimed to determine whether plastic particle exposure poses additional toxic risk to people whose airways are already compromised.
Detection of Microplastics in Human Bronchoalveolar Lavage Fluid: Preliminary Evidence of Respiratory Exposure to Environmental Contaminants
Researchers analyzed bronchoalveolar lavage fluid from eight adult patients undergoing diagnostic bronchoscopy and detected microplastics in the samples using microscopy, providing preliminary direct evidence that airborne microplastics deposit in the human respiratory tract.
Impact of occupational exposures in patients with chronic obstructive pulmonary disease: current understanding and knowledge gaps
This study reviews the relationship between occupational exposures and chronic obstructive pulmonary disease (COPD), noting that workplace pollutants including dust and particulate matter contribute to disease development. The authors highlight significant knowledge gaps in understanding how occupational exposures, including microplastic particles, affect COPD pathogenesis. They call for more research into precision medicine approaches and workplace interventions to reduce occupational respiratory risks.
Microplastics, potential threat to patients with lung diseases
This review examines the potential threat that airborne microplastics pose to people with existing lung conditions, noting that these particles have been found in human lung tissue and sputum. Researchers explored possible mechanisms by which inhaled microplastics could worsen lung diseases, including triggering inflammation and oxidative stress. The study highlights significant knowledge gaps and calls for more research into how microplastic inhalation affects respiratory health.
Detection and Analysis of Microplastics in Human Sputum
Researchers analyzed sputum (mucus from the lungs) from 22 patients with respiratory diseases and found microplastics in every single sample, identifying 21 different plastic types. Polyurethane was the most common type detected, and most particles were smaller than 500 micrometers. This study provides direct evidence that humans are inhaling microplastics, with factors like smoking and medical procedures increasing the amount found in the respiratory tract.